MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 56 filers reported holding MERSANA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $79,790 | -97.9% | 62,827 | -94.5% | 0.00% | -100.0% |
| Q2 2023 | $3,743,174 | -20.6% | 1,137,743 | -0.9% | 0.00% | -33.3% |
| Q1 2023 | $4,716,446 | -28.8% | 1,147,554 | +1.5% | 0.00% | -25.0% |
| Q4 2022 | $6,625,925 | -12.4% | 1,130,704 | +1.1% | 0.00% | -20.0% |
| Q3 2022 | $7,564,000 | +45.6% | 1,118,862 | -0.5% | 0.01% | +66.7% |
| Q2 2022 | $5,196,000 | +12.7% | 1,124,715 | -2.7% | 0.00% | +50.0% |
| Q1 2022 | $4,612,000 | +862.8% | 1,155,677 | +1400.6% | 0.00% | – |
| Q4 2021 | $479,000 | -51.2% | 77,012 | -26.1% | 0.00% | – |
| Q3 2021 | $982,000 | -63.2% | 104,207 | -46.9% | 0.00% | -100.0% |
| Q2 2021 | $2,666,000 | -24.9% | 196,326 | -10.5% | 0.00% | -50.0% |
| Q1 2021 | $3,549,000 | -41.2% | 219,398 | -3.2% | 0.00% | -50.0% |
| Q4 2020 | $6,033,000 | -62.5% | 226,679 | -73.8% | 0.00% | -63.6% |
| Q3 2020 | $16,109,000 | +1080.1% | 865,127 | +1383.3% | 0.01% | +1000.0% |
| Q2 2020 | $1,365,000 | +2000.0% | 58,326 | +421.4% | 0.00% | – |
| Q1 2020 | $65,000 | -4.4% | 11,186 | -6.1% | 0.00% | – |
| Q4 2019 | $68,000 | -20.9% | 11,912 | -78.4% | 0.00% | – |
| Q3 2019 | $86,000 | -69.8% | 55,054 | -21.9% | 0.00% | – |
| Q2 2019 | $285,000 | -69.6% | 70,504 | -60.5% | 0.00% | -100.0% |
| Q1 2019 | $938,000 | +1300.0% | 178,568 | +971.8% | 0.00% | – |
| Q4 2018 | $67,000 | -88.2% | 16,660 | -70.7% | 0.00% | – |
| Q3 2018 | $568,000 | -41.9% | 56,953 | +3.9% | 0.00% | – |
| Q2 2018 | $978,000 | +263.6% | 54,833 | +220.0% | 0.00% | – |
| Q1 2018 | $269,000 | +43.9% | 17,137 | +50.3% | 0.00% | – |
| Q4 2017 | $187,000 | +29.9% | 11,405 | +35.0% | 0.00% | – |
| Q3 2017 | $144,000 | +171.7% | 8,447 | +122.3% | 0.00% | – |
| Q2 2017 | $53,000 | – | 3,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
| VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
| Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
| EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
| Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
| 5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
| COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
| Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |